Paul A. Volberding

28.9k total citations · 15 hit papers
191 papers, 19.8k citations indexed

About

Paul A. Volberding is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Paul A. Volberding has authored 191 papers receiving a total of 19.8k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Infectious Diseases, 58 papers in Virology and 46 papers in Epidemiology. Recurrent topics in Paul A. Volberding's work include HIV/AIDS Research and Interventions (91 papers), HIV/AIDS drug development and treatment (73 papers) and HIV Research and Treatment (58 papers). Paul A. Volberding is often cited by papers focused on HIV/AIDS Research and Interventions (91 papers), HIV/AIDS drug development and treatment (73 papers) and HIV Research and Treatment (58 papers). Paul A. Volberding collaborates with scholars based in United States, France and Australia. Paul A. Volberding's co-authors include Douglas D. Richman, Margaret A. Fischl, Donna M. Jacobsen, Melanie Thompson, Robert T. Schooley, Scott M. Hammer, Michael S. Saag, Martin Hirsch, Patrick Yéni and Joseph J. Eron and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Paul A. Volberding

186 papers receiving 18.8k citations

Hit Papers

The Efficacy of Azidothym... 1987 2026 2000 2013 1987 2012 1987 1990 2000 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
    1987 2.3k citations Paul A. Volberding et al. profile →
  2. Antiretroviral Treatment of Adult HIV Infection
    2012 1.4k citations Joseph J. Eron, Donna M. Jacobsen et al. profile →
  3. The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
    1987 975 citations Paul A. Volberding et al. profile →
  4. Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
    1990 951 citations Paul A. Volberding, Robert L. Murphy et al. profile →
  5. Antiretroviral Therapy in Adults
    2000 874 citations Donna M. Jacobsen, Michael S. Saag et al. profile →
  6. Antiretroviral Therapy for HIV Infection in 1998
    1998 837 citations Donna M. Jacobsen, Michael S. Saag et al. profile →
  7. Antiretroviral Treatment of Adult HIV Infection
    2008 832 citations Joseph J. Eron, Donna M. Jacobsen et al. profile →
  8. Treatment for Adult HIV Infection
    2006 767 citations Michael S. Saag, Donna M. Jacobsen et al. profile →
  9. Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons
    2004 674 citations Paul A. Volberding et al. profile →
  10. Treatment for Adult HIV Infection
    2004 601 citations Michael S. Saag, Donna M. Jacobsen et al. profile →
  11. Antiretroviral Treatment of Adult HIV Infection
    2010 595 citations Donna M. Jacobsen, Paul A. Volberding et al. profile →
  12. Antiretroviral Treatment for Adult HIV Infection in 2002
    2002 573 citations Donna M. Jacobsen, Michael S. Saag et al. profile →
  13. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
    2016 478 citations Michael S. Saag, Constance A. Benson et al. profile →
  14. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
    2018 401 citations Michael S. Saag, Constance A. Benson et al. profile →
  15. Antiretroviral Treatment of Adult HIV Infection
    2014 352 citations Joseph J. Eron, Constance A. Benson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paul A. Volberding 13.9k 10.0k 5.8k 3.0k 1.7k 191 19.8k
Margaret A. Fischl 16.5k 1.2× 12.5k 1.2× 6.8k 1.2× 3.4k 1.1× 1.1k 0.7× 268 23.5k
Adriano Lazzarin 12.2k 0.9× 10.9k 1.1× 6.2k 1.1× 3.4k 1.2× 2.3k 1.4× 616 20.6k
Brian Gazzard 12.2k 0.9× 8.9k 0.9× 7.0k 1.2× 3.3k 1.1× 1.3k 0.8× 494 21.8k
John Phair 11.0k 0.8× 9.5k 0.9× 7.6k 1.3× 3.0k 1.0× 1.6k 1.0× 353 22.0k
Jean‐Michel Molina 11.4k 0.8× 7.2k 0.7× 5.9k 1.0× 2.6k 0.9× 1.3k 0.8× 547 18.7k
Dominique Costagliola 9.0k 0.6× 7.3k 0.7× 5.6k 1.0× 3.9k 1.3× 1.0k 0.6× 450 17.8k
Martin Hirsch 13.6k 1.0× 13.0k 1.3× 7.2k 1.2× 2.4k 0.8× 1.1k 0.7× 274 24.1k
Antonella d’Arminio Monforte 14.6k 1.0× 9.5k 0.9× 6.7k 1.2× 8.8k 3.0× 1.6k 1.0× 485 21.9k
Andrea Antinori 9.9k 0.7× 7.4k 0.7× 4.1k 0.7× 3.0k 1.0× 786 0.5× 561 15.4k
Joel E. Gallant 11.9k 0.9× 9.7k 1.0× 4.3k 0.7× 3.4k 1.2× 929 0.6× 156 15.8k

Countries citing papers authored by Paul A. Volberding

Since Specialization
Citations

This map shows the geographic impact of Paul A. Volberding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Volberding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Volberding more than expected).

Fields of papers citing papers by Paul A. Volberding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Volberding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Volberding. The network helps show where Paul A. Volberding may publish in the future.

Co-authorship network of co-authors of Paul A. Volberding

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Volberding. A scholar is included among the top collaborators of Paul A. Volberding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Volberding. Paul A. Volberding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Etemad, Behzad, Christy L. Lavine, Yijia Li, et al.. (2023). Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption. Science Translational Medicine. 15(695). eabq4490–eabq4490. 12 indexed citations
2.
Harding, Barbara N, Bridget M. Whitney, Robin M. Nance, et al.. (2020). Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study. BMJ Open. 10(3). e031487–e031487. 6 indexed citations
3.
4.
Volberding, Paul A.. (2017). HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel.. PubMed. 25(1). 17–24. 16 indexed citations
5.
Kiser, Gretchen, et al.. (2014). The Resource Allocation Program at the University of California, San Francisco: Getting More from Intramural Funding Bucks.. 45(1). 81–104. 1 indexed citations
6.
Chu, Carissa, Fengshi Wu, Xi He, et al.. (2014). Exploring the Social Meaning of Curing HIV: A Qualitative Study of People Who Inject Drugs in Guangzhou, China. AIDS Research and Human Retroviruses. 31(1). 78–84. 32 indexed citations
7.
Walensky, Rochelle P., Judith D. Auerbach, Judith D. Auerbach, et al.. (2014). Focusing National Institutes of Health HIV/AIDS Research for Maximum Population Impact. Clinical Infectious Diseases. 60(6). 937–940. 4 indexed citations
8.
Volberding, Paul A.. (2012). Sande's HIV/AIDS medicine, Medical management of AIDS 2012. Elsevier eBooks. 9 indexed citations
9.
Volberding, Paul A.. (2011). The impact of HIV research on health outcome and healthcare policy. Annals of Oncology. 22. vii50–vii53. 4 indexed citations
10.
Choi, Andy I., Yongmei Li, Steven G. Deeks, et al.. (2010). Association Between Kidney Function and Albuminuria With Cardiovascular Events in HIV-Infected Persons. Circulation. 121(5). 651–658. 140 indexed citations
11.
Choi, Andy I., Yongmei Li, Chirag R. Parikh, Paul A. Volberding, & Michael G. Shlipak. (2010). Long-term clinical consequences of acute kidney injury in the HIV-infected. Kidney International. 78(5). 478–485. 96 indexed citations
12.
Holodniy, Mark, et al.. (2006). Relationship Between Antiretroviral Prescribing Patterns and Treatment Guidelines in Treatment-Naive HIV-1-Infected US Veterans (1992-2004). JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(1). 20–29. 23 indexed citations
13.
Volberding, Paul A.. (2006). Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Triple Combination Tablet. Drugs. 66(11). 1513–1514. 2 indexed citations
14.
Behler, Caroline, et al.. (2005). Anemia and HIV in the Antiretroviral Era: Potential Significance of Testosterone. AIDS Research and Human Retroviruses. 21(3). 200–206. 20 indexed citations
15.
Kilby, J Michael, Jacob Lalezari, Joseph J. Eron, et al.. (2003). The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults. AIDS Research and Human Retroviruses. 19(1). 83–83. 6 indexed citations
16.
Kilby, J Michael, Jacob Lalezari, Joseph J. Eron, et al.. (2002). The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults. AIDS Research and Human Retroviruses. 18(10). 685–693. 152 indexed citations
17.
Gerbert, Barbara, James C. Moe, Michael S. Saag, et al.. (2001). Toward a Definition of HIV Expertise: A Survey of Experienced HIV Physicians. AIDS Patient Care and STDs. 15(6). 321–330. 13 indexed citations
18.
Gerbert, Barbara, Brandon Brown, Paul A. Volberding, et al.. (1999). Physicians' Transmission Prevention Assessment and Counseling Practices with Their HIV Positive Patients. AIDS Education and Prevention. 11(4). 307–320. 18 indexed citations
19.
Stryker, Richard, et al.. (1992). A Phase I Study of HGP-30, a 30 Amino Acid Subunit of the Human Immunodeficiency Virus (HIV) p17 Synthetic Peptide Analogue Sub-unit Vaccine in Seronegative Subjects. AIDS Research and Human Retroviruses. 8(8). 1321–1325. 18 indexed citations
20.
Volberding, Paul A., et al.. (1987). Therapy of Acquired Immune Deficiency Syndrome with Recombinant Interleukin-2. AIDS Research and Human Retroviruses. 3(2). 115–124. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret A. Fischl Breakdown of academic impact, for papers by Adriano Lazzarin Breakdown of academic impact, for papers by Brian Gazzard Breakdown of academic impact, for papers by John Phair Breakdown of academic impact, for papers by Jean‐Michel Molina Breakdown of academic impact, for papers by Dominique Costagliola Breakdown of academic impact, for papers by Martin Hirsch Breakdown of academic impact, for papers by Antonella d’Arminio Monforte Breakdown of academic impact, for papers by Andrea Antinori Breakdown of academic impact, for papers by Joel E. Gallant
Rankless by CCL
2026